PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH)

Clinical trials for PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH) explained in plain language.

Never miss a new study

Get alerted when new PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH) trials appear

Sign up with your email to follow new studies for PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New pill offers hope for stubborn anemia in rare blood disease

Disease control Completed

This study tested whether a new tablet called HSK39297 could help patients with a rare blood disease called PNH who still have low red blood cell counts (anemia) despite being on standard antibody therapy. The goal was to see if the tablet could safely raise hemoglobin levels eno…

Matched conditions: PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH)

Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH)

Get alerted when new PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH) trials appear

New pill offers hope for stubborn anemia in rare blood disease